Brief: Coherus Biosciences Inc CFO Mcdavid Stilwell To Resign
Dec 7 (Reuters) - Coherus BioSciences Inc CHRS.O :
* COHERUS BIOSCIENCES INC- MCDAVID STILWELL NOTIFIED
COMPANY ON
DECEMBER 7, 2023 OF HIS RESIGNATION AS CHIEF FINANCIAL OFFICER
* COHERUS BIOSCIENCES INC- MCDAVID STILWELL'S RESIGNATION
IS
EFFECTIVE ON DECEMBER 31, 2023
* COHERUS BIOSCIENCES INC- STILWELL TO ALSO RESIGN AS
PRINCIPAL
FINANCIAL OFFICER AND EMPLOYEE OF COMPANY
Further company coverage: CHRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million